Wednesday, May 22, 2024

Oracle director sells $2.9m in stock, buys options at $42.02 By Investing.com

Must read



Oracle Corp (NYSE:) director George H. Conrades executed significant transactions in the company’s stock, according to a recent SEC filing. Conrades sold 25,000 shares of Oracle at a weighted average price of $116.1276, totaling approximately $2.9 million. On the same day, he also acquired an equivalent number of options to buy shares at $42.02 each, investing over $1 million.

The sales were carried out in multiple trades, with prices ranging from $116.00 to $116.29 per share, reflecting the weighted average sales price reported in the filing. The filing included a footnote indicating Conrades’ commitment to provide full information about the specific shares and prices upon request.

Conrades’ transactions demonstrate a reshuffling of his investment in Oracle, as he continues to hold a significant number of shares and options in the company. Following these transactions, he owns 17,836 direct shares of common stock and maintains options for an additional 20,000 shares.

Investors often monitor insider transactions like these for insights into executives’ perspectives on their company’s stock. While the reasons behind Conrades’ decisions are not disclosed, the transactions are a matter of public record for Oracle’s shareholders and the broader investment community.

The stock options acquired by Conrades have a vesting schedule, with 25% vesting annually on each anniversary of the grant date, as noted in the filing’s footnotes. This detail provides context for the timing of potential future transactions related to these options.

Oracle’s stock performance and executive trading activities are closely watched indicators of the company’s health and executive confidence. As such, this recent filing will likely be of interest to current and potential investors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

InvestingPro Insights

Oracle Corp (NYSE:ORCL) has been a topic of interest for investors, especially in light of recent insider transactions. To provide a more comprehensive understanding of Oracle’s financial standing, key metrics from InvestingPro are presented.

InvestingPro Data shows Oracle’s Market Cap is a robust $315.25 billion, reflecting its significant presence in the market. The company’s P/E Ratio stands at 29.62, which may suggest a premium valuation compared to near-term earnings growth, as the P/E Ratio (Adjusted) for the last twelve months as of Q3 2024 is 27.68. Additionally, Oracle has demonstrated a solid Revenue Growth of 9.49% over the same period, indicating its ability to expand its financial base.

Two InvestingPro Tips that may be particularly relevant to investors in the context of the article are as follows: Oracle has maintained dividend payments for 16 consecutive years, showcasing a commitment to returning value to shareholders. Furthermore, Oracle is considered a prominent player in the Software industry, which may contribute to investor confidence in the company’s market position and long-term strategy.

For those considering a deeper analysis, there are more InvestingPro Tips available, including insights on earnings revisions and valuation multiples. By visiting https://www.investing.com/pro/ORCL, readers can access a total of 11 additional InvestingPro Tips to further inform their investment decisions.

To enhance the value of this information, readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. This offer could be particularly useful for those who closely follow insider transactions and company performance metrics to guide their investment strategies.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.



More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article